Tcf-1 promotes genomic instability and T cell transformation in response to aberrant β-catenin activation

被引:7
|
作者
Arnovitz, Stephen [1 ]
Mathur, Priya [1 ]
Tracy, Melissa [1 ]
Mohsin, Azam [1 ]
Mondal, Soumi [1 ]
Quandt, Jasmin [1 ]
Hernandez, Kyle M. [1 ]
Khazaie, Khashayarsha [2 ]
Dose, Marei [1 ]
Emmanuel, Akinola Olumide [1 ]
Gounari, Fotini [1 ,2 ]
机构
[1] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[2] Mayo Clin, Dept Immunol, Scottsdale, AZ 85259 USA
关键词
genomic instability; T-ALL; beta-catenin; Tcf-1; TRANSCRIPTION FACTORS; V(D)J RECOMBINATION; PTEN; GENETICS; LEUKEMIA; IDENTITY; SPECIFICATION; MECHANISMS; INITIATION; COMPLEXES;
D O I
10.1073/pnas.2201493119
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Understanding the mechanisms promoting chromosomal translocations of the rearranging receptor loci in leukemia and lymphoma remains incomplete. Here we show that leukemias induced by aberrant activation of beta-catenin in thymocytes, which bear recurrent Tcra/Myc-Pvt1 translocations, depend on Tcf-1. The DNA double strand breaks (DSBs) in the Tcra site of the translocation are Rag-generated, whereas the Myc-Pvt1 DSBs are not. Aberrantly activated beta-catenin redirects Tcf-1 binding to novel DNA sites to alter chromatin accessibility and down-regulate genome-stability pathways. Impaired homologous recombination (HR) DNA repair and replication checkpoints lead to retention of DSBs that promote translocations and transformation of double-positive (DP) thymocytes. The resulting lymphomas, which resemble human T cell acute lymphoblastic leukemia (T-ALL), are sensitive to PARP inhibitors (PARPis). Our findings indicate that aberrant beta-catenin signaling contributes to translocations in thymocytes by guiding Tcf-1 to promote the generation and retention of replication-induced DSBs allowing their coexistence with Rag-generated DSBs. Thus, PARPis could offer therapeutic options in hematologic malignancies with activeWnt/beta-catenin signaling.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Liver X receptor controls follicular helper T cell differentiation via repression of TCF-1
    Kim, Jiyeon
    Lee, Haeseung
    Lee, Jeong-Eun
    Choi, Garam
    Chung, Hayeon
    Kim, Daehong
    Park, Min Jung
    Gye, Yong Seok
    Shin, Kwang-Soo
    Kang, Chang-Yuil
    Kwok, Seung-Ki
    Chung, Yeonseok
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (09)
  • [32] TCF-1 dictates lung tissue resident helper T cell and memory B cell development during flu
    Mcgee, Michael C.
    Magazine, Nicholas
    Zhang, Tianyi
    Babawale, Pius
    Huang, Weishan
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [33] TCF-1 and LEF-1 promote CD4+T cell lineage choice by upregulating Myb
    Steinke, Farrah
    Zhou, Xinyuan
    Yu, Shuyang
    Xue, Hai-Hui
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [34] Exploring the stage-specific roles of Tcf-1 in T cell development and malignancy at single-cell resolution
    Fang Wang
    Zhihong Qi
    Yingpeng Yao
    Guotao Yu
    Tao Feng
    Tianyan Zhao
    Hai-Hui Xue
    Yaofeng Zhao
    Peng Jiang
    Li Bao
    Shuyang Yu
    Cellular & Molecular Immunology, 2021, 18 : 644 - 659
  • [35] Exploring the stage-specific roles of Tcf-1 in T cell development and malignancy at single-cell resolution
    Wang, Fang
    Qi, Zhihong
    Yao, Yingpeng
    Yu, Guotao
    Feng, Tao
    Zhao, Tianyan
    Xue, Hai-Hui
    Zhao, Yaofeng
    Jiang, Peng
    Bao, Li
    Yu, Shuyang
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (03) : 644 - 659
  • [36] The TCF-1 and LEF-1 Transcription Factors Have Cooperative and Opposing Roles in T Cell Development and Malignancy
    Yu, Shuyang
    Zhou, Xinyuan
    Steinke, Farrah C.
    Liu, Chengyu
    Chen, Shann-Ching
    Zagorodna, Oksana
    Jing, Xuefang
    Yokota, Yoshifumi
    Meyerholz, David K.
    Mullighan, Charles G.
    Knudson, C. Michael
    Zhao, Dong-Mei
    Xue, Hai-Hui
    IMMUNITY, 2012, 37 (05) : 813 - 826
  • [37] Inhibition of Peroxisome Proliferator-Activated Receptor γ Promotes Tumorigenesis Through Activation of the β-Catenin/T Cell Factor (TCF) Pathway in the Mouse Intestine
    Fujisawa, Toshio
    Sugiyama, Michiko
    Tomimoto, Ayako
    Wada, Koichiro
    Endo, Hiroki
    Takahashi, Hirokazu
    Yoneda, Kyoko
    Yoneda, Masato
    Inamori, Masahiko
    Saito, Satoru
    Terauchi, Yasuo
    Kadowaki, Takashi
    Tsuchiya, Naoto
    Nakagama, Hitoshi
    Nakajima, Atsushi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 108 (04) : 535 - 544
  • [38] TCF-1 regulates effector T cell responses upon FTY720 treatment in multiple sclerosis
    Gandhi, Roopali
    Mazzola, Maria
    Raheja, Radhika
    Gopal, Murugaiyan
    Rajabi, Hasan
    Kumar, Deepak
    Pertel, Thomas
    Regev, Keren
    Griffin, Russell
    Aly, Lilian
    Kivisakk, Pia
    Nejad, Parham
    Patel, Bonny
    Gwanyalla, Nguen
    Hey, Hillary
    Glanz, Bonnie
    Chitnis, Tanuja
    Weiner, Howard L.
    Gandhi, Roopali
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [39] Redundant regulation of T cell differentiation and TCRα gene expression by the transcription factors LEF-1 and TCF-1
    Okamura, RM
    Sigvardsson, M
    Galceran, J
    Verbeek, S
    Clevers, H
    Grosschedl, R
    IMMUNITY, 1998, 8 (01) : 11 - 20
  • [40] Loss of expression of the WNT/β-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor-1 (TCF-1) in a subset of peripheral T cell lymphomas
    Dorfman, DM
    Greisman, HA
    Shahsafaei, A
    AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (05): : 1539 - 1544